Aardvark Therapeutics (AARD) Other Non-Current Assets (2024 - 2026)

Aardvark Therapeutics (AARD) has 3 years of Other Non-Current Assets data on file, last reported at $4.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 157.24% year-over-year to $4.7 million; the trailing twelve-month figure through Mar 2026 stood at $4.7 million (up 157.24% YoY), and the FY2025 full-year result was $4.9 million, up 87.48% from the prior year.
• Other Non-Current Assets eased to $4.7 million in Q1 2026, from $4.9 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $4.9 million in Q4 2025 to a low of $1.8 million in Q1 2025.
• A 3-year average of $3.3 million and a median of $3.1 million in 2024 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets surged 87.48% in 2025 and soared 157.24% in 2026, its largest moves.
• Tracing AARD's Other Non-Current Assets over 3 years: stood at $2.6 million in 2024, then surged by 87.48% to $4.9 million in 2025, then dropped by 4.03% to $4.7 million in 2026.
• Business Quant data shows AARD's Other Non-Current Assets at $4.7 million in Q1 2026, $4.9 million in Q4 2025, and $3.6 million in Q3 2025.